Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Impact BioMedical, Inc. ( (IBO) ) is now available.
On July 21, 2025, Impact BioMedical Inc. entered into a Debt Conversion Agreement with DSS, Inc. to settle a $12 million loan originally made in March 2023. The agreement involves the issuance of 31,939,778 shares of common stock to DSS, fully satisfying the debt and any additional financial support provided by DSS up to the transaction’s closing.
More about Impact BioMedical, Inc.
Average Trading Volume: 11,314,788
Technical Sentiment Signal: Strong Sell
For an in-depth examination of IBO stock, go to TipRanks’ Overview page.